|
|
Article: Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis.(ARTICLES)
- Article from:
- Journal of Drugs in Dermatology
- Article date:
- July 1, 2004
- Author:
CopyrightCOPYRIGHT 2004 Journal of Drugs in Dermatology, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Abstract
Psoriasis is a chronic, papulosquamous condition that affects up to 2% of the U.S. population. Approximately 50% of patients with psoriasis have involvement of the scalp.
This was a multicentre, randomized, vehicle-controlled, double-masked and parallel-group study. The aim was to evaluate the efficacy and safety of clobetasol propionate shampoo, 0.05% versus its corresponding vehicle in subjects aged 12 years and older with moderate to severe scalp psoriasis over a treatment period of 4 weeks. Recurrence of scalp psoriasis was assessed during a two week follow-up period.
A total of 142 subjects were treated. Results after 4 weeks ...